Kirk Binns

A Molecular Biologist by training, Kirk Binns was a founding shareholder of MediPharm Labs. A serial entrepreneur, Kirk has spent most of his career in the North American deregulated energy markets, leading market expansions, client acquisitions and managed up to 100 reports across multiple markets. Over the last 12 years, he established and ran a multinational energy sales organization generating 7-figures annually, while also contributing to MediPharm Labs’ start-up and operations. Kirk takes on the role of EVP, Global Accounts to help MediPharm Labs realize its vision as the trusted global leader in cannabinoid-based derivatives.